| Tretinoin | Approved Investigational Nutraceutical | ASCL1 | 429 |
downregulated | Tretinoin results in decreased expression of ASCL1 mRNA | 12q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ASCL1 | 429 |
upregulated | Tretinoin results in increased expression of ASCL1 mRNA | 12q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ASCL2 | 430 |
downregulated | Tretinoin results in decreased expression of ASCL2 mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | ASF1B | 55723 |
downregulated | Tretinoin results in decreased expression of ASF1B mRNA | 19p13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ASIC1 | 41 |
downregulated | Tretinoin results in decreased expression of ASIC1 mRNA | 12q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ASIC1 | 41 |
upregulated | Tretinoin results in increased expression of ASIC1 mRNA | 12q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | ASIC2 | 40 |
upregulated | Tretinoin results in increased expression of ASIC2 mRNA | 17q11.2-q12 | |
| Tretinoin | Approved Investigational Nutraceutical | ASIC4 | 55515 |
upregulated | Tretinoin results in increased expression of ASIC4 mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | ASL | 435 |
upregulated | Tretinoin results in increased expression of ASL mRNA | 7q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | ASMTL | 8623 |
downregulated | Tretinoin results in decreased expression of ASMTL mRNA | Xp22.3 and Yp11.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ASNA1 | 439 |
upregulated | Tretinoin results in increased expression of ASNA1 mRNA | 19p13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ASPH | 444 |
downregulated | Tretinoin results in decreased expression of ASPH mRNA | 8q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ASPHD1 | 253982 |
downregulated | Tretinoin results in decreased expression of ASPHD1 mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ASPHD2 | 57168 |
downregulated | Tretinoin results in decreased expression of ASPHD2 mRNA | 22q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ASS1 | 445 |
downregulated | Tretinoin results in decreased expression of ASS1 mRNA | 9q34.11 | |
| Tretinoin | Approved Investigational Nutraceutical | ASTN1 | 460 |
downregulated | Tretinoin results in decreased expression of ASTN1 mRNA | 1q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ASTN2 | 23245 |
downregulated | Tretinoin results in decreased expression of ASTN2 mRNA | 9q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ATAD2 | 29028 |
downregulated | Tretinoin results in decreased expression of ATAD2 mRNA | 8q24.13 | |
| Tretinoin | Approved Investigational Nutraceutical | ATCAY | 85300 |
downregulated | Tretinoin results in decreased expression of ATCAY mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ATF3 | 467 |
upregulated | Tretinoin results in increased expression of ATF3 mRNA | 1q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ATF5 | 22809 |
downregulated | Tretinoin results in decreased expression of ATF5 mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ATF6 | 22926 |
upregulated | Tretinoin results in increased expression of ATF6 mRNA | 1q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ATM | 472 |
upregulated | Tretinoin results in increased expression of ATM mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ATOH1 | 474 |
upregulated | Tretinoin results in increased expression of ATOH1 mRNA | 4q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ATOH8 | 84913 |
upregulated | Tretinoin results in increased expression of ATOH8 mRNA | 2p11.2 | |